ask="3.3100"
ask_size="400"
average_daily_volume="3958"
bid="0.0001"
bid_size="100"
book_value="0.9570"
change="-0.0899"
change_from_200_day_moving_average="-0.5501"
change_from_50_day_moving_average="-0.3572"
change_from_52_week_high="-2.7399"
change_From_52_week_low="0.2901"
change_in_percent="-3.4577%"
close="2.5101"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.4410"
ebitda="-13.35M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="-0.0700"
eps_estimate_next_year="-0.3300"
ex_dividend_date="N/A"
float_shares="23083000"
high="2.5200"
high_52_weeks="5.2500"
last_trade_date="2/10/2017"
last_trade_price="2.5101"
last_trade_size="100"
last_trade_time="3:04pm"
low="2.5100"
low_52_weeks="2.2200"
market_capitalization="89.70M"
moving_average_200_day="3.0602"
moving_average_50_day="2.8673"
name="Oasmia Pharmaceutical AB - Amer"
notes="N/A"
one_year_target_price="6.0000"
open="2.5200"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-17.9765%"
percent_change_from_50_day_moving_average="-12.4568%"
percent_change_from_52_week_high="-52.1886%"
percent_change_from_52_week_low="+13.0676%"
previous_close="2.6000"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.7168"
price_per_sales="50.8518"
revenue="1.83M"
shares_outstanding="35736000"
short_ratio="8.1300"
stock_exchange="NCM"
symbol="OASM"
volume="2300"
weeks_range_52="2.2200 - 5.2500"
